160
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Effects of MTHFR and ABCC2 gene polymorphisms on antiepileptic drug responsiveness in Jordanian epileptic patients

, , , , , & show all
Pages 87-95 | Published online: 10 Jun 2019

References

  • Sadr SS, Javanbakht J, Javidan AN, Ghaffarpour M, Khamse S, Naghshband Z. Descriptive epidemiology: prevalence, incidence, sociodemographic factors, socioeconomic domains, and quality of life of epilepsy: an update and systematic review. Arch Med Sci. 2018;14(4):717–724. doi:10.5114/aoms.2016.6037730002687
  • Birbeck GL. Epilepsy care in developing countries: part I of II. Epilepsy Curr. 2010;10(4):75–79. doi:10.1111/j.1535-7511.2010.01362.x20697498
  • Cowan LD. The epidemiology of the epilepsies in children. Ment Retard Dev Disabil Res Rev. 2002;8(3):171–181. doi:10.1002/mrdd.1003512216061
  • Banerjee PN, Filippi D, Allen Hauser W. The descriptive epidemiology of epilepsy – a review. Epilepsy Res. 2009;85(1):31–45.19369037
  • Myers CT, Mefford HC. Advancing epilepsy genetics in the genomic era. Genome Med. 2015;7:91.26302787
  • Poduri A, Lowenstein D. Epilepsy genetics–past, present, and future. Curr Opin Genet Dev. 2011;21(3):325–332.21277190
  • Steinlein OK. Genes and mutations in human idiopathic epilepsy. Brain Dev. 2004;26(4):213–218.15130686
  • Berkovic SF, Howell RA, Hay DA, Hopper JL. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann Neurol. 1998;43(4):435–445.9546323
  • Kjeldsen MJ, Kyvik KO, Friis ML, Christensen K. Genetic and environmental factors in febrile seizures: a Danish population-based twin study. Epilepsy Res. 2002;51(1–2):167–177.12350392
  • Kjeldsen MJ, Corey LA, Christensen K, Friis ML. Epileptic seizures and syndromes in twins: the importance of genetic factors. Epilepsy Res. 2003;55(1–2):137–146.12948623
  • Orlandi A, Paolino MC, Striano P, Parisi P. Clinical reappraisal of the influence of drug-transporter polymorphisms in epilepsy. Expert Opin Drug Metab Toxicol. 2018;14(5):505–512. doi:10.1080/17425255.2018.147337729804481
  • Loscher W, Klotz U, Zimprich F, Schmidt D. The clinical impact of pharmacogenetics on the treatment of epilepsy. Epilepsia. 2009;50(1):1–23. doi:10.1111/j.1528-1167.2008.01716.x
  • Loscher W, Potschka H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther. 2002;301(1):7–14.11907151
  • Dean M, Rzhetsky A, Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 2001;11(7):1156–1166. doi:10.1101/gr.18490111435397
  • Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst. 2000;92(16):1295–1302. doi:10.1093/jnci/92.16.129510944550
  • Zimprich F, Sunder-Plassmann R, Stogmann E, et al. Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy. Neurology. 2004;63(6):1087–1089. doi:10.1212/01.wnl.0000141021.42763.f615452305
  • Muhrez K, Largeau B, Emond P, et al. Single nucleotide polymorphisms of ABCC2 modulate renal secretion of endogenous organic anions. Biochem Pharmacol. 2017;140:124–138. doi:10.1016/j.bcp.2017.05.01228532626
  • Ibbotson K, Yell J, Ronaldson PT. Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress. Fluids Barriers CNS. 2017;14(1):6. doi:10.1186/s12987-017-0054-528298215
  • Kwan P, Brodie MJ. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy. Epilepsia. 2005;46(2):224–235. doi:10.1111/j.0013-9580.2005.31904.x15679503
  • Lazarowski A, Lubieniecki F, Camarero S, et al. Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy. Pediatr Neurol. 2004;30(2):102–106. doi:10.1016/S0887-8994(03)00407-714984901
  • Mazerska Z, Mroz A, Pawlowska M, Augustin E. The role of glucuronidation in drug resistance. Pharmacol Ther. 2016;159:35–55. doi:10.1016/j.pharmthera.2016.01.00926808161
  • Li HY, Liu F, Wang HR. Correlation between Nurr1 expression and drug resistance in the brain of rats with epilepsy. Eur Rev Med Pharmacol Sci. 2018;22(5):1506–1513. doi:10.26355/eurrev_201803_1450029565514
  • D’Aco KE, Bearden D, Watkins D, Hyland K, Rosenblatt DS, Ficicioglu C. Severe 5,10-methylenetetrahydrofolate reductase deficiency and two MTHFR variants in an adolescent with progressive myoclonic epilepsy. Pediatr Neurol. 2014;51(2):266–270. doi:10.1016/j.pediatrneurol.2014.04.00525079578
  • Parrish RR, Buckingham SC, Mascia KL, et al. Methionine increases BDNF DNA methylation and improves memory in epilepsy. Ann Clin Transl Neurol. 2015;2(4):401–416. doi:10.1002/acn3.18325909085
  • Belcastro V, Striano P. Antiepileptic drugs, hyperhomocysteinemia and B-vitamins supplementation in patients with epilepsy. Epilepsy Res. 2012;102(1–2):1–7. doi:10.1016/j.eplepsyres.2012.07.00322824326
  • Urreizti R, Moya-Garcia AA, Pino-Angeles A, et al. Molecular characterization of five patients with homocystinuria due to severe methylenetetrahydrofolate reductase deficiency. Clin Genet. 2010;78(5):441–448. doi:10.1111/j.1399-0004.2010.01391.x20236116
  • Schiff M, Benoist JF, Tilea B, Royer N, Giraudier S, Ogier de Baulny H. Isolated remethylation disorders: do our treatments benefit patients? J Inherit Metab Dis. 2011;34(1):137–145. doi:10.1007/s10545-010-9120-820490923
  • Ogier de Baulny H, Gerard M, Saudubray JM, Zittoun J. Remethylation defects: guidelines for clinical diagnosis and treatment. Eur J Pediatr. 1998;157(2):S77–S83.9587031
  • Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International league against epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):522–530. doi:10.1111/epi.1367028276060
  • Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):512–521. doi:10.1111/epi.1370928276062
  • AL-Eitan LN, Al-Dalalah IM, Elshammari AK, Khreisat WH, Almasri AY. The impact of potassium channel gene polymorphisms on antiepileptic drug responsiveness in Arab patients with epilepsy. J Pers Med. 2018;8(4):37. doi:10.3390/jpm8040037
  • Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia. 2010;51(6):1069–1077. doi:10.1111/j.1528-1167.2009.02397.x19889013
  • Schneider JA, Rees DC, Liu YT, Clegg JB. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet. 1998;62(5):1258–1260. doi:10.1086/3018369545406
  • Boduroglu K, Alikasifoglu M, Anar B, Tuncbilek E. 677–>CT mutation on the methylenetetrahydrofolate reductase gene is not a risk factor for neural tube defects in Turkey. Arch Dis Child Fetal Neonatal Ed. 1998;78(3):F235. doi:10.1136/fn.78.3.F234c
  • Morita H, Taguchi J, Kurihara H, et al. [Gene polymorphism of 5, 10-methylenetetrahydrofolate reductase as a coronary risk factor]. J Cardiol. 1997;29(6):309–315.9211089
  • Shaw GM, Rozen R, Finnell RH, Wasserman CR, Lammer EJ. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am J Epidemiol. 1998;148(1):30–37. doi:10.1093/oxfordjournals.aje.a0095559663401
  • Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000;151(9):862–877.10791559
  • Hamidi AK, Yazdani N, Seyedjavadi KH, et al. MTHFR AND ApoE genetic variants association with sudden sensorineural hearing loss. Am J Otolaryngol. 2019;40(2):260–264.30477909
  • Wu YL, Ding XX, Sun YH, Yang HY, Sun L. Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson’s disease: a meta-analysis. J Neurol Sci. 2013;335(1–2):14–21.24064257
  • Hua Y, Zhao H, Kong Y, Ye M. Association between the MTHFR gene and Alzheimer’s disease: a meta-analysis. Int J Neurosci. 2011;121(8):462–471.21663380
  • Azimova JE, Sergeev AV, Korobeynikova LA, et al. Effects of MTHFR gene polymorphism on the clinical and electrophysiological characteristics of migraine. BMC Neurol. 2013;13:103.23915182
  • Scher AI, Wu H, Tsao JW, et al. MTHFR C677T genotype as a risk factor for epilepsy including post-traumatic epilepsy in a representative military cohort. J Neurotrauma. 2011;28(9):1739–1745.21787169
  • Wu YL, Yang HY, Ding XX, et al. Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: a meta-analysis. Seizure. 2014;23(6):411–416.24556013
  • Xue T, Lu ZN. Association between the polymorphisms in the ATP-binding cassette genes ABCB1 and ABCC2 and the risk of drug-resistant epilepsy in a Chinese Han population. Genet Mol Res. 2016;15(4).
  • Zhou L, Cao Y, Long H, et al. ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population. Pharmazie. 2015;70(6):416–420.26189305
  • Grover S, Kukreti R. A systematic review and meta-analysis of the role of ABCC2 variants on drug response in patients with epilepsy. Epilepsia. 2013;54(5):936–945.23506516
  • Hilger E, Reinthaler EM, Stogmann E, et al. Lack of association between ABCC2 gene variants and treatment response in epilepsy. Pharmacogenomics. 2012;13(2):185–190.22256867
  • Qu J, Zhou BT, Yin JY, et al. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients. CNS Neurosci Ther. 2012;18(8):647–651.22630058
  • Ufer M, von Stulpnagel C, Muhle H, et al. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy. Pharmacogenet Genomics. 2011;21(10):624–630.21799461
  • Seo T, Ishitsu T, Oniki K, Abe T, Shuto T, Nakagawa K. ABCC2 haplotype is not associated with drug-resistant epilepsy. J Pharm Pharmacol. 2008;60(5):631–635.18416940
  • Ma CL, Wu XY, Zheng J, Wu ZY, Hong Z, Zhong MK. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy. Pharmacogenomics. 2014;15(10):1323–1336.25155934
  • Kwan P, Wong V, Ng PW, et al. Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy. Pharmacogenomics. 2011;12(3):319–325.21449672